Skip to main content
. 2015 Nov 20;4(11):e002155. doi: 10.1161/JAHA.115.002155

Table 2.

Association of BP Group With Incident Cardiovascular Disease in Different Multivariable‐Adjusted Models in the Overall Sample (n=3024)

BP Group, mm Hg BP Treatment No. Events/No. at Risk Person‐Years Crude Event Rates (95% CI)a HR (95% CI)b P Value HR (95% CI)c P Value
1 <120/80 No 65/909 9997 0.65 (0.51–0.83) 1 1
2 ≥120/80 to <140/90 No 116/970 10 170 1.14 (0.95–1.37) 1.35 (1.00–1.84) 0.054 1.36 (1.00–1.85) 0.053
3 <140/90 Yes 80/393 3842 2.08 (1.67–2.59) 1.92 (1.36–2.71) 0.0002 1.60 (1.08–2.38) 0.020
4 ≥140/90 No 88/413 4091 2.15 (1.75–2.64) 1.94 (1.39–2.71) 0.0001 1.97 (1.39–2.79) 0.0001
5 ≥140/90 Yes 100/339 3125 3.20 (2.64–3.88) 2.44 (1.74–3.43) <0.0001 1.96 (1.30–2.98) 0.0015
Total 449/3024 31 225 1.44 (1.31–1.58)

BP indicates blood pressure; HDL, high‐density lipoprotein; HR, hazard ratio.

a

Events per 100 person‐years.

b

HRs are adjusted for age, sex, total and HDL cholesterol, intake of lipid‐lowering medication, smoking, diabetes, aspirin use, and estimated glomerular filtration rate.

c

HRs are adjusted for age, sex, total and HDL cholesterol, intake of lipid‐lowering medication, smoking, diabetes, aspirin use, estimated glomerular filtration rate, duration of hypertension, and duration of hypertension treatment.